Biological Evaluation of Synergistic Drug Combinations, Design and Synthesis of Potent and Selective PI3K Inhibitors and the Design of Bifunctional Ligands Incorporating Pictilisib & Ceritinib for the Treatment of EML4-ALK Positive Lung Cancer
Lung cancer remains the leading cause of cancer death in the United Kingdom. Non-small cell lung cancer makes up the majority of all lung cancers, approximately 80-85%. Of these non-small cell lung cancers, 3-7% possess chromosomal rearrangements of anaplastic lymphoma kinase (ALK). These lead to co...
| Main Author: | |
|---|---|
| Format: | Thesis (University of Nottingham only) |
| Language: | English |
| Published: |
2019
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/56580/ |